Combination immunotherapy before surgery may increase survival in people with head and neck cancer
March 13, 2025
Robert Ferris, MD, PhD, and colleagues report in Cancer Cell that head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy drug.